FGF-2, together with VEGF and IGF, all secreted by MM plasma cells and inflammatory cells, promotes the recruitment of bone marrow stem cells and progenitor cells into the tumor microenvironment. The gene discussed is VEGFA; the disease is Miyoshi myopathy.